Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Patient Preference for Goserelin Microsphere vs Implant in Prostate Cancer
NCT06385847Phase 2Recruiting
- Sponsor
- First Affiliated Hospital of Xiamen University
- Start
- May 2024
- Primary completion
- May 2025
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Baituowei in prostate cancer (PCa), sponsored by First Affiliated Hospital of Xiamen University. Started May 2024; status: recruiting.
02
Drugs
Baituowei
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT06385847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06385847.